Located in Geneva, I am a member of Covance’s Scientific Affairs team, partnering with clients and internal staff to address scientific and regulatory challenges, and ensuring that the global bioanalytical groups are positioned with the right technologies and expertise to effectively support the evolving needs of pharmaceutical drug development. My primary area of focus is bioanalytical science aspects of clinical and nonclinical studies, particularly pharmacokinetic, pharmacodynamics, biomarker and immunogenicity endpoints. I am excited to grow our experience with patient centric approaches for large molecule bioanalysis, improving processes and expanding capabilities that allow clinical trial participants and patients to have choices for their sample collection.
“The future is not some place we are going, but one we are creating. The paths are not to be found, but made. And the activity of making them changes both the maker and the destination.” ― John H. Schaar